Zeng Wei-Juan, Hu Wen-Qin, Wang Lin-Wei, Yan Shu-Guang, Li Jian-Ding, Zhao Hao-Liang, Peng Chun-Wei, Yang Gui-Fang, Li Yan
Departments of Oncology and Pathology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors and Hubei Cancer Clinical Study Center, Wuhan, Hubei 430071, P.R. China.
Oncol Lett. 2013 Dec;6(6):1693-1700. doi: 10.3892/ol.2013.1615. Epub 2013 Oct 10.
To study the clinical significance of lymph node ratio (LNR) in gastric cancer (GC), this study analyzed 613 patients with GC who underwent surgical resection. Of 613 patients with GC, 138 patients who had >15 lymph nodes (LNs) resected and radical resection were enrolled into the final study. All major clinicopathological data were entered into a central database. LNR was defined as the ratio of the number of metastatic LNs to the number of removed LNs. In order to determine the best cut-off points for LNR, the log-rank test and X-tile were used. LNR was then substituted for lymph node status (pN) in the 7th American Joint Committee on Cancer tumor-node-metastases (TNM) staging system and this was defined as the tumor-node ratio-metastases (TRM) staging system. Pearson's correlation coefficient (r) was used to study the correlations among the number of removed LNs, pN and LNR. The Kaplan-Meier survival curve was used to study the survival status, and the log-rank test and Cox proportional hazards model were used to identify the independent factors for survival. Receiver operating characteristic curve analysis was used to determine the predictive value of the parameters. By the time of last follow-up (median follow-up period, 38.3 months; range, 9.9-97.7 months), the median overall survival (OS) was 23.9 months [95% confidence interval (CI), 18.8-29.0 months]. The 1-, 2-, 3- and 5-year survival rates were 76.8, 57.2, 50.0 and 46.4%, respectively. The cut-off points were 0, 0.5 and 0.8 (R0, LNR=0; R1, LNR ≤0.5; R2, 0.5> LNR ≤0.8; and R3, LNR >0.8). Univariate and multivariate analyses revealed that both LNR and pN were independent prognostic factors for GC. LNR could better differentiate OS in patients than LN. In addition, the TRM staging system was better at predicting the clinical outcomes than the TNM staging system, and LNR was better than pN. In conclusion, LNR was a better prognosticator than pN for GC.
为研究淋巴结比率(LNR)在胃癌(GC)中的临床意义,本研究分析了613例行手术切除的GC患者。在613例GC患者中,138例切除淋巴结(LN)>15枚且行根治性切除术的患者被纳入最终研究。所有主要临床病理数据均录入中央数据库。LNR定义为转移LN数与切除LN数之比。为确定LNR的最佳截断点,采用了对数秩检验和X-tile软件。然后将LNR代入美国癌症联合委员会(AJCC)第7版肿瘤-淋巴结-转移(TNM)分期系统中的淋巴结状态(pN),并将此定义为肿瘤-淋巴结比率-转移(TRM)分期系统。采用Pearson相关系数(r)研究切除LN数、pN和LNR之间的相关性。采用Kaplan-Meier生存曲线研究生存状况,采用对数秩检验和Cox比例风险模型确定生存的独立因素。采用受试者工作特征曲线分析确定各参数的预测价值。截至末次随访时(中位随访期38.3个月;范围9.9 - 97.7个月),中位总生存期(OS)为23.9个月[95%置信区间(CI),18.8 - 29.0个月]。1年、2年、3年和5年生存率分别为76.8%、57.2%、50.0%和46.4%。截断点分别为0、0.5和0.8(R0,LNR = 0;R1,LNR≤0.5;R2,0.5 < LNR≤0.8;R3,LNR > 0.8)。单因素和多因素分析显示,LNR和pN均为GC的独立预后因素。与LN相比,LNR能更好地区分患者的OS。此外,TRM分期系统在预测临床结局方面优于TNM分期系统,且LNR优于pN。总之,对于GC,LNR是比pN更好的预后指标。